We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
AUM
$1.32B
AUM Growth
-$76M
Cap. Flow
-$67.2M
Cap. Flow %
-5.08%
Top 10 Hldgs %
11.52%
Holding
283
New
27
Increased
60
Reduced
140
Closed
36

Sector Composition

Rank Sector Weight
1 Financials 16.58%
2 Industrials 14.97%
3 Consumer Discretionary 14.59%
4 Technology 13.6%
5 Healthcare 12.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZD icon
26
Ziff Davis
ZD
$2B
$12.4M 0.94%
157,056
-12,064
-7% -$914K
MEDP icon
27
Medpace
MEDP
$16.3B
$12.3M 0.93%
145,964
+77,220
+112% +$5.83M
MTZ icon
28
MasTec
MTZ
$22.7B
$12.2M 0.92%
188,308
+88,565
+89% +$5.17M
ALRM icon
29
Alarm.com
ALRM
$2.75B
$12.1M 0.91%
259,381
+104,020
+67% +$5.1M
ENTA icon
30
Enanta Pharmaceuticals
ENTA
$362M
$12.1M 0.91%
200,771
-10,507
-5% -$780K
CORE
31
DELISTED
Core Mark Holding Co., Inc.
CORE
$12M 0.91%
373,230
+227,814
+157% +$7.92M
NAVI icon
32
Navient
NAVI
$819M
$11.9M 0.9%
929,614
-53,046
-5% -$707K
ALGT icon
33
Allegiant Air
ALGT
$2.57B
$11.9M 0.9%
79,356
-5,210
-6% -$763K
GBCI icon
34
Glacier Bancorp
GBCI
$6.36B
$11.8M 0.89%
291,714
-70,542
-19% -$2.82M
PRSP
35
DELISTED
Perspecta Inc. Common Stock
PRSP
$11.8M 0.89%
451,030
+137,877
+44% +$3.37M
SUPN icon
36
Supernus Pharmaceuticals
SUPN
$2.7B
$11.6M 0.88%
423,230
+305,082
+258% +$9.04M
PDM
37
Piedmont Realty Trust
PDM
$1.24B
$11.6M 0.87%
553,664
-31,621
-5% -$638K
BJRI icon
38
BJ's Restaurants
BJRI
$1.47B
$11.5M 0.87%
296,263
-17,142
-5% -$661K
MMI icon
39
Marcus & Millichap
MMI
$1.2B
$11.3M 0.85%
318,025
-79,458
-20% -$2.71M
AAPL icon
40
Apple
AAPL
$4.97T
$11.3M 0.85%
201,016
+152,936
+318% +$8M
EGBN icon
41
Eagle Bancorp
EGBN
$850M
$11.2M 0.84%
250,261
-15,043
-6% -$657K
SIGI icon
42
Selective Insurance
SIGI
$5.76B
$11.1M 0.84%
148,121
-26,694
-15% -$2.06M
LRN icon
43
Stride
LRN
$4.16B
$11.1M 0.84%
419,118
-23,012
-5% -$661K
AMKR icon
44
Amkor Technology
AMKR
$10.6B
$11.1M 0.84%
1,214,274
-322,745
-21% -$2.77M
OMF icon
45
OneMain Financial
OMF
$7.27B
$11M 0.83%
299,800
-103,424
-26% -$3.84M
RGEN icon
46
Repligen
RGEN
$6.91B
$10.9M 0.82%
141,519
+33,239
+31% +$2.91M
MGRC icon
47
McGrath RentCorp
MGRC
$2.87B
$10.5M 0.79%
150,557
-13,266
-8% -$870K
ANIK icon
48
Anika Therapeutics
ANIK
$215M
$10.4M 0.79%
189,980
+159,891
+531% +$8.21M
EVR icon
49
Evercore
EVR
$11.8B
$10.1M 0.77%
126,667
-7,071
-5% -$586K
WNC icon
50
Wabash National
WNC
$504M
$10.1M 0.76%
696,169
-74,845
-10% -$1.11M

Similar funds

Matarin Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Matarin Capital Management held 283 positions worth $1.32B, down 5.4% from $1.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Matarin Capital Management withdrew a net $67.2M in Q3 2019, closing 36 positions and reducing 140 holdings. Its most notable exit was Sotheby's, an estimated $18.1M position sold in full.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 17% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Matarin Capital Management opened a new position in Group 1 Automotive worth $14.5M.

  • Matarin Capital Management's largest Q3 2019 buy was Group 1 Automotive: 156,695 shares worth $14.5M.
  • Matarin Capital Management added most to U S Concrete, Inc. in Q3 2019, an estimated $10.5M increase.
  • Matarin Capital Management's biggest Q3 2019 reduction was ANI Pharmaceuticals, cutting an estimated $8.39M.
  • Matarin Capital Management fully exited Sotheby's in Q3 2019, selling an estimated $18.1M.
  • Matarin Capital Management's ten largest holdings make up 12% of its $1.32B portfolio in Q3 2019.
  • Matarin Capital Management opened 27 new positions and closed 36 in Q3 2019.
  • Matarin Capital Management's portfolio value fell 5.4% quarter-over-quarter to $1.32B.

Based on Matarin Capital Management's 13F filing for Q3 2019, filed 5 Nov 2019.